Keyword: Centers for Medicare & Medicaid Services
Medtronic walked away from Responsive Orthopedics, which it bought three years ago to disrupt the knee replacement market with cheaper joints.
The U.S. government has formed an interagency task force to guide the rapid deployment of in vitro diagnostic tests during public health emergencies.
Officials put the rule forward to enable earlier Medicare coverage of medical devices, only to withdraw it nine months later.
CMS covers traditional insulin pumps, but not tubeless patch pumps, causing concern around innovation as well as patient access.
F1CDx is an NGS-based test to detect alterations in 324 genes relevant to a range of solid tumors.
Hospitals enrolled in Medicare will soon receive reimbursement for HeartFlow's noninvasive technology for coronary artery disease analysis.
Theranos and Walgreens have reached a tentative agreement to put the latter's breach-of-contract lawsuit to rest, WSJ sources say.
Theranos settled two lawsuits with Partner Fund Management, which backed the embattled blood-testing startup with a $96.1 million investment in 2014.
Theranos promised CMS it will not run a lab for two years and settled to pay up $4.65 million to Arizona residents who had taken Theranos blood tests.
The Centers for Medicare & Medicaid Services published criteria for coverage of therapeutic continuous glucose monitoring systems.